Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
HCA.MX
STRONG BUYFLAGHCA Healthcare, Inc. · Healthcare · United States · $86.9B · Avg Vol: $11K/d
HCA Healthcare has strong quality Q78 and value V69, but momentum at M40 is below the calibrated floor, so stage one fails.
COMPANY DESCRIPTION
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology...
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 60.2B | 65.0B | 70.6B | 75.6B | 7.9% | 76.4B | 78.5B | 81.9B | 4.1% |
| EPS | 19.43 | 19.74 | 23.04 | 30.20 | 15.8% | 29.07 | — | — | — |
| Shares | 277.4M | 265.5M | 250.0M | 224.6M | -19.0% | 221.8M | — | — | — |
| Debt | 40.2B | 41.9B | 45.2B | 48.7B | 6.6% | 49.8B | — | — | — |
| Equity | -2.8B | -1.8B | -2.5B | -6.0B | — | — | — | — | — |
| Op CF | 8.5B | 9.4B | 10.5B | 12.6B | 14.0% | 13.0B | — | — | — |
| Inv CF | -3.4B | -5.3B | -4.9B | -5.0B | — | — | — | — | — |
| Fin CF | -5.7B | -4.1B | -4.6B | -8.6B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of HCA.MX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HCA.MX | HCA Healthcare, Inc.(you) | $86.9B | 93 | STRONG BUY |
| THC | Tenet Healthcare Corporation | $20.1B | 99 | STRONG BUY |
| DVA | DaVita Inc. | $15.1B | 96 | STRONG BUY |
| FMS | Fresenius Medical Care AG | $13.2B | 97 | STRONG BUY |
| FRE.DE | Fresenius SE & Co. KGaA | $25.5B | 72 | BUY |
| EHC | Encompass Health Corporation | $11.2B | 89 | STRONG BUY |
| UHS | Universal Health Services, Inc. | $9.4B | 88 | STRONG BUY |
| CHE | Chemed Corporation | $6.8B | 88 | STRONG BUY |
| PACS | PACS Group, Inc. | $7.4B | 78 | BUY |
| NHC | National HealthCare Corporation | $3.5B | 90 | STRONG BUY |
Peer medians: ROE 2.1% · P/E 23.4x · Gross margin 50.1%